HRSA further delays effective date of final rule on 340B drug ceiling prices
The Health Resources and Services Administration today to May 22 the effective date of its on 340B drug ceiling prices and civil monetary penalties for manufacturers, and invited comments on whether a delay to Oct. 1 would be more appropriate. The rule was set to take effect March 21 following an earlier two-week . 鈥淸The Department of Health and Human Services] believes that the delay of the effective date is necessary to consider questions of fact, law and policy raised in the rule, consistent with the 鈥楻egulatory Freeze Pending Review鈥 memorandum,鈥 the notice states. 鈥淚n addition, HHS believes that the delay of the effective date is necessary to provide regulated entities sufficient time to implement the requirements of the rule.鈥 HRSA will accept comments through April 17.